Published April 28, 2026 | Version v1
Preprint Open

Circulating BTK protein levels as precision therapy biomarker

Authors/Creators

  • 1. MedicOath

Description

Quantification of residual BTK protein and phospho-BTK (Y551) in patient plasma correlates with treatment responsiveness, enabling personalized selection between protein stabilizers, gene therapy, or immunoglobulin replacement based on molecular subtype

Notes

IPFS: QmX619ooZ2cxkEdrgBtWYWkmkLV85Y1rxH762s6p4QVVGf. TX: 0xe3b0bc4fd14c75e818c4748bc1755eec73864ed41ece859f0726ef88ff3e50c6. CC0.

Files

hypothesis.json

Files (361 Bytes)

Name Size Download all
md5:c2a716202d86744bab115c991063cd29
361 Bytes Preview Download